Very early researchNot Yet RecruitingNCT07458919What this trial is testingTherapy for Advanced NSCLC With EGFR 19delins MutationWho this might be right forLung Cancer Fuzhou General Hospital 94
Not applicableStudy completedNCT01208467What this trial is testingPrognostic Biomarkers in Patients With Endometrial CancerWho this might be right forEndometrial AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage I Uterine Corpus Cancer+3 more Gynecologic Oncology Group 2,824
Testing effectiveness (Phase 2)Ended earlyNCT04030429What this trial is testingCrizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial CancerWho this might be right forEndometrial Cancer Recurrent National Cheng-Kung University Hospital 40
Not applicableStudy completedNCT02827357What this trial is testingResponses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 MutationWho this might be right forLung Cancer University Hospital, Toulouse 101
Early research (Phase 1)Ended earlyNCT01611675What this trial is testingLeflunomide+Vemurafenib in V600 Mutant Met. MelanomaWho this might be right forMelanoma Massachusetts General Hospital 3
Not applicableStudy completedNCT04961619What this trial is testingAdjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.Who this might be right forMelanoma Novartis Pharmaceuticals 39
Not applicableStudy completedNCT01353300What this trial is testingGene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing CancerWho this might be right forBrain and Central Nervous System TumorsHereditary Wilms TumorKidney Cancer+4 more Children's Oncology Group 31
Testing effectiveness (Phase 2)Study completedNCT03037385What this trial is testingPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more Hoffmann-La Roche 590
Testing effectiveness (Phase 2)UnknownNCT05135715What this trial is testingRC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)Who this might be right forMelanoma, Stage IIHER2-positiveAdvanced Melanoma RemeGen Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT03544814What this trial is testingEGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual ProgressionWho this might be right forLung AdenocarcinomaEGFR Activating Mutation Shanghai Chest Hospital 99
Early research (Phase 1)Study completedNCT02608034What this trial is testingInvestigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady StateWho this might be right forMetastatic Melanoma, BRAF V600 Mutation Positive Genentech, Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT07322263What this trial is testingIntravesical GEM/DOCE for HR BCG-Unresponsive NMIBCWho this might be right forBladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more Michael A. O'Donnell 174
Not applicableUnknownNCT04651933What this trial is testingA Training Set for the HRD Model in EOCWho this might be right forEpithelial Ovarian CancerBRCA MutationLoss of Heterozygosity+3 more Lei Li 200
Testing effectiveness (Phase 2)Looking for participantsNCT06728865What this trial is testingEvaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical StudyWho this might be right forNon-small Cell Lung Cancer (NSCLC)EGFR Mutation-Positive Lung CancerBrain Metastases+2 more Li-kun Chen 70
Early research (Phase 1)Study completedNCT01877811What this trial is testingStudy of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid TumorsWho this might be right forSolid Tumors Hoffmann-La Roche 143
Testing effectiveness (Phase 2)Looking for participantsNCT06563999What this trial is testingNeoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.Who this might be right forLung Cancer Stage IIIMutation Sun Yat-sen University 120
Testing effectiveness (Phase 2)WithdrawnNCT05041972What this trial is testingARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)Who this might be right forHER2 Mutation-Related TumorsHER2 Amplified Solid Tumors Ambrx, Inc.
Testing effectiveness (Phase 2)Study completedNCT03652857What this trial is testingApatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung CancerWho this might be right forAdvanced Non Small Cell Lung Cancer Yongchang Zhang 30
Not applicableEnded earlyNCT02483416What this trial is testingEvaluation of the Impact of Nurse-led Telephone on Treatment ComplianceWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 30
Early research (Phase 1)UnknownNCT03703063What this trial is testingAlternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerWho this might be right forPancreatic Adenocarcinoma Benaroya Research Institute 30